78 related articles for article (PubMed ID: 16756021)
1. [Role of metadoxyl in the treatment of the hepatotoxic effects of cytostatics].
Safonova SA; Gershanovich ML
Vopr Onkol; 2005; 51(5):599-600. PubMed ID: 16756021
[No Abstract] [Full Text] [Related]
2. [Metadoxyl in combined treatment of alcohol damage to the liver].
Vedrova NN; Gnezdilova NIu
Klin Med (Mosk); 2001; 79(4):56-8. PubMed ID: 11496744
[TBL] [Abstract][Full Text] [Related]
3. [Non-alcoholic fatty liver disease: age peculiarities, breakthrough in pathogenetic therapy].
Pal'tsev AI; Sharapov IV; Gorbunova EN; Khomchenko TN; Kurganova IV; Soldatova GS; Eremina AA; Nikolaev IuA
Eksp Klin Gastroenterol; 2009; (8):19-25. PubMed ID: 20469674
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of alcoholic liver diseases. Abstinence, nutritional support, drug therapy, liver transplantation].
Pár A
Orv Hetil; 2000 Apr; 141(16):827-33. PubMed ID: 10817009
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic use of metadoxine in alcohol-related mental and behavioral disorders].
Carboni MA; Corsa R
Clin Ter; 1987 Dec; 123(6):469-73. PubMed ID: 2972505
[No Abstract] [Full Text] [Related]
6. Combined metadoxine and garlic oil treatment efficaciously abrogates alcoholic steatosis and CYP2E1 induction in rat liver with restoration of AMPK activity.
Ki SH; Choi JH; Kim CW; Kim SG
Chem Biol Interact; 2007 Aug; 169(2):80-90. PubMed ID: 17606256
[TBL] [Abstract][Full Text] [Related]
7. [The use of hepatic protectors in clinical practice].
Minushkin ON; Maslovskiĭ LV; Bukshuk AA
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(10 Pt 2):67-72. PubMed ID: 23250615
[No Abstract] [Full Text] [Related]
8. [Treatment of alcoholic hepatic steatosis with metadoxine. Preliminary results on the evaluation of the effects of the drug by an ultrasonographic study].
Sergiacomo L; Ciancaglini R; Orlando D; Delle Monache G; Pesa O
Clin Ter; 1986 Oct; 119(2):133-41. PubMed ID: 3539468
[No Abstract] [Full Text] [Related]
9. [Metadoxine in the treatment of vomiting in uremic patients under dialysis treatment].
Di Paolo N; De Mia M; Gaggiotti E
Clin Ter; 1984 Aug; 110(3):221-9. PubMed ID: 6237861
[No Abstract] [Full Text] [Related]
10. Salvage plasmapheresis for small-for-size syndrome following hepatic resection for colorectal liver metastases.
Sotiropoulos GC; Lang H; Herget-Rosenthal S; Molmenti EP; Baba HA; Karaliotas C; Broelsch CE; Saner FH
Int J Colorectal Dis; 2008 May; 23(5):553. PubMed ID: 18060418
[No Abstract] [Full Text] [Related]
11. [The treatment of alcoholism with metadoxil].
Iakovlev VA
Voen Med Zh; 1999 Oct; 320(10):57-9. PubMed ID: 10605344
[No Abstract] [Full Text] [Related]
12. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases.
Aloia T; Sebagh M; Plasse M; Karam V; Lévi F; Giacchetti S; Azoulay D; Bismuth H; Castaing D; Adam R
J Clin Oncol; 2006 Nov; 24(31):4983-90. PubMed ID: 17075116
[TBL] [Abstract][Full Text] [Related]
13. [A case of liver failure associated with liver damage due to mFOLFOX 6 after resection for multiple liver metastases from colorectal cancer].
Ishizaki T; Abe T; Koyanagi Y; Katsumata K; Wada T; Tsuchida A; Aoki T
Gan To Kagaku Ryoho; 2007 Jun; 34(6):945-8. PubMed ID: 17565263
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of metadoxine for injection after repeated doses in healthy volunteers.
Lü Y; Kang ZS; Liu Y; Li TY; Xiao YH
Chin Med J (Engl); 2007 Jan; 120(2):166-8. PubMed ID: 17335665
[No Abstract] [Full Text] [Related]
15. [Metadoxine in alcohol-related pathology].
Santoni S; Corradini P; Zocchi M; Camarri F
Clin Ter; 1989 Jul; 130(2):115-22. PubMed ID: 2529084
[TBL] [Abstract][Full Text] [Related]
16. Pyridoxol L,2-pyrrolidon-5 carboxylate prevents active fibroplasia in CCl4-treated rats.
Annoni G; Contu L; Tronci MA; Caputo A; Arosio B
Pharmacol Res; 1992 Jan; 25(1):87-93. PubMed ID: 1310810
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic contribution of pyrodoxine pyrrolidinecarboxylate. (Notes on antiseborrheic treatment).
Ghittoni S; Orsucci O; Saviozzi A; Simonini P
Ital Gen Rev Dermatol; 1978; 15(1):39-61. PubMed ID: 162287
[No Abstract] [Full Text] [Related]
18. [Clinical efficacy of ademetionine "Heptor" in the therapy of alcohol-dependent liver disease].
Tkachenko EI; Uspenskiĭ IuP; Skvortsova TE
Eksp Klin Gastroenterol; 2008; (2):106-12. PubMed ID: 19145875
[No Abstract] [Full Text] [Related]
19. Cisplatin as single-agent chemotherapy in patients with liver dysfunction due to metastases.
Wilop S; Dada R; Galm O; Jousten P; Osieka R; Jost E
Onkologie; 2009 Jul; 32(7):400-4. PubMed ID: 19556817
[TBL] [Abstract][Full Text] [Related]
20. Treatment of alcoholic fatty liver: is the metabolic effect of metadoxine the only reason for improved liver function?
Stefanini GF; Addolorato G; Caputo F; Bernardi M; Gasbarrini G
J Hepatol; 1999 Apr; 30(4):739-40. PubMed ID: 10207820
[No Abstract] [Full Text] [Related]
[Next] [New Search]
